1.79
price up icon0.56%   0.01
after-market Dopo l'orario di chiusura: 1.79
loading
Precedente Chiudi:
$1.78
Aprire:
$1.78
Volume 24 ore:
7,786
Relative Volume:
0.24
Capitalizzazione di mercato:
$65.02M
Reddito:
$134.00K
Utile/perdita netta:
$-9.93M
Rapporto P/E:
-4.8378
EPS:
-0.37
Flusso di cassa netto:
$-6.72M
1 W Prestazione:
-5.29%
1M Prestazione:
-4.28%
6M Prestazione:
-17.13%
1 anno Prestazione:
+192.05%
Intervallo 1D:
Value
$1.78
$1.82
Intervallo di 1 settimana:
Value
$1.77
$1.9357
Portata 52W:
Value
$0.52
$3.35

Entera Bio Ltd Stock (ENTX) Company Profile

Name
Nome
Entera Bio Ltd
Name
Telefono
972-2-532-7151
Name
Indirizzo
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Name
Dipendente
19
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
ENTX's Discussions on Twitter

Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-03-22 Iniziato Aegis Capital Buy

Entera Bio Ltd Borsa (ENTX) Ultime notizie

pulisher
Oct 29, 2024

Short Interest in Entera Bio Ltd. (NASDAQ:ENTX) Drops By 14.4% - MarketBeat

Oct 29, 2024
pulisher
Oct 13, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Up 38.4% in September - MarketBeat

Oct 13, 2024
pulisher
Oct 07, 2024

Entera Bio outlook steady as H.C. Wainwright backs potential of total hip BMD in osteoporosis care - Investing.com Australia

Oct 07, 2024
pulisher
Oct 07, 2024

Entera Bio (NASDAQ:ENTX) Rating Reiterated by HC Wainwright - MarketBeat

Oct 07, 2024
pulisher
Oct 04, 2024

Are Medical Stocks Lagging Argenx (ARGX) This Year? - Yahoo Finance

Oct 04, 2024
pulisher
Sep 30, 2024

ENTX & OPK Stock May Gain Following Positive PK/PD Research Data - MSN

Sep 30, 2024
pulisher
Sep 29, 2024

Entera Bio shares hold Buy rating on OXM study success By Investing.com - Investing.com Australia

Sep 29, 2024
pulisher
Sep 28, 2024

Entera Bio shares hold Buy rating on OXM study success - Investing.com

Sep 28, 2024
pulisher
Sep 27, 2024

Entera Bio's (ENTX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Sep 27, 2024
pulisher
Sep 26, 2024

Entera Bio and OPKO Health report promising obesity treatment study By Investing.com - Investing.com Australia

Sep 26, 2024
pulisher
Sep 25, 2024

Entera Bio and OPKO Health report promising obesity treatment study - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

Entera Bio And Opko Health Provide Update On Pk/Pd Results Of Oral Oxyntomodulin (Glp-1/Glucagon) Peptide Tablet Candidate For Obesity And Metabolic Disorders - XM

Sep 25, 2024
pulisher
Sep 25, 2024

Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide - EIN News

Sep 25, 2024
pulisher
Sep 20, 2024

Is Entera Bio (ENTX) Stock Outpacing Its Medical Peers This Year? - MSN

Sep 20, 2024
pulisher
Sep 03, 2024

Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year? - MSN

Sep 03, 2024
pulisher
Sep 01, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Sees Significant Increase in Short Interest - MarketBeat

Sep 01, 2024
pulisher
Aug 30, 2024

We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate - Yahoo Finance

Aug 30, 2024
pulisher
Aug 20, 2024

Entera Bio to Participate in Upcoming Investor and Scientific Conferences - GlobeNewswire

Aug 20, 2024
pulisher
Aug 15, 2024

All You Need to Know About Entera Bio (ENTX) Rating Upgrade to Buy - Yahoo Finance

Aug 15, 2024
pulisher
Aug 15, 2024

Entera Bio Ltd. Forecasted to Earn Q3 2024 Earnings of ($0.05) Per Share (NASDAQ:ENTX) - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

Entera Bio Ltd. to Post Q3 2024 Earnings of ($0.05) Per Share, HC Wainwright Forecasts (NASDAQ:ENTX) - MarketBeat

Aug 15, 2024
pulisher
Aug 13, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 51.0% in July - MarketBeat

Aug 13, 2024
pulisher
Aug 12, 2024

Entera Bio (NASDAQ:ENTX) Releases Earnings Results - MarketBeat

Aug 12, 2024
pulisher
Aug 12, 2024

Entera Bio's (ENTX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Aug 12, 2024
pulisher
Aug 12, 2024

HC Wainwright Reiterates Buy Rating for Entera Bio (NASDAQ:ENTX) - Defense World

Aug 12, 2024
pulisher
Aug 09, 2024

Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates - GlobeNewswire

Aug 09, 2024
pulisher
Aug 09, 2024

Virtu Financial LLC Invests $37,000 in Entera Bio Ltd. (NASDAQ:ENTX) - Defense World

Aug 09, 2024
pulisher
Aug 07, 2024

Entera Bio Ltd expected to post a loss of 6 cents a shareEarnings Preview - XM

Aug 07, 2024
pulisher
Aug 06, 2024

The 10 Best Biotech Stocks Under $5 To Buy For September 2024! - The Stock Dork

Aug 06, 2024
pulisher
Aug 02, 2024

Entera Bio shareholders approve executive compensation, board appointments - Investing.com

Aug 02, 2024
pulisher
Aug 01, 2024

Entera’s EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual MeetingKey SABRE Update Also Expected - StockTitan

Aug 01, 2024
pulisher
Aug 01, 2024

Entera Bio (NASDAQ:ENTX) Trading Up 1.9% - MarketBeat

Aug 01, 2024
pulisher
Aug 01, 2024

Entera Bio (NASDAQ:ENTX) Stock Price Up 1.9% - Defense World

Aug 01, 2024
pulisher
Jul 28, 2024

Entera Bio (NASDAQ:ENTX) & Vericel (NASDAQ:VCEL) Financial Survey - Defense World

Jul 28, 2024
pulisher
Jul 27, 2024

Short bowel syndrome Market Positive Outlook: Phase Bio , Orphan Technologies , Zealand Pharma - Newstrail

Jul 27, 2024
pulisher
Jul 23, 2024

3 Meme Stocks to Buy and Hold for Potential 300% Returns in 3 Years - Markets Insider

Jul 23, 2024
pulisher
Jul 09, 2024

Entera Bio (NASDAQ:ENTX) Trading 6% Higher - MarketBeat

Jul 09, 2024
pulisher
Jul 09, 2024

Entera Bio (NASDAQ:ENTX) Stock Price Up 6% - Defense World

Jul 09, 2024
pulisher
Jun 29, 2024

Entera Bio Announces Execution of Key Regulatory Milestones for EB613, the First Oral Anabolic Drug Proposed for ... - Barchart

Jun 29, 2024
pulisher
Jun 20, 2024

Rags to Riches: 3 Penny Stocks That Could Make Early Investors Rich - Markets Insider

Jun 20, 2024
pulisher
Jun 20, 2024

Head to Head Contrast: Entera Bio (NASDAQ:ENTX) and HilleVax (NASDAQ:HLVX) - Defense World

Jun 20, 2024
pulisher
Jun 19, 2024

Aegis Capital initates Entera Bio Ltd (ENTX) rating to a Buy – Knox Daily - Knox Daily

Jun 19, 2024
pulisher
Jun 19, 2024

Entera Bio Ltd (ENTX)'s stock rises to 2.11 per share – US Post News - US Post News

Jun 19, 2024
pulisher
Jun 15, 2024

Entera Bio Ltd. (ENTX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo New Zealand News

Jun 15, 2024
pulisher
Jun 13, 2024

Entera Bio (ENTX) to Report Q4 Earnings: What's in the Cards? - Yahoo Lifestyle Singapore

Jun 13, 2024
pulisher
Jun 10, 2024

Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024 - Markets Insider

Jun 10, 2024
pulisher
Jun 07, 2024

Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar - Yahoo Finance

Jun 07, 2024

Entera Bio Ltd Azioni (ENTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Entera Bio Ltd Azioni (ENTX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Taitel Haya
Director
Jan 10 '24
Buy
0.77
7,615
5,864
25,615
LIEBERMAN GERALD M
Director
Dec 22 '23
Buy
0.71
23,952
17,006
226,961
Toledano Miranda Jayne
Chief Executive Officer
Dec 22 '23
Buy
0.71
23,952
17,006
110,752
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):